Elevate Healthcare, Inc.

Elevate Healthcare, Inc., doing business as CAE Healthcare USA Inc., is a manufacturer of medical simulation equipment and training solutions that operates as a prime contractor delivering to the federal government on 1,758 awards with combined potential value of $470.1 million. The company is a for-profit subsidiary of Canadian-based CAE Inc. and competes in full-and-open federal procurements without set-aside designations. Elevate Healthcare is headquartered in Sarasota, Florida and maintains a federal contracting footprint dating to 2002 across civilian and defense healthcare customers.

Elevate Healthcare's core capability is the design, manufacture, and support of patient simulators, ultrasound training systems, clinical skills models, and learning management platforms used to train healthcare professionals across military and federal civilian medical systems. The company delivers both capital equipment and consumables, including patient simulator maintenance, replacement parts, software licenses, instructor-led training courses, and installation services. Representative work includes a $236.5 million delivery order from the Defense Logistics Agency Troop Support Medical for an adult human patient simulator for anesthesia training, a $79.6 thousand firm fixed-price purchase order from the U.S. Army Training and Doctrine Command for repair and maintenance services on HPS964 and HPS010 human patient simulators supporting the Army Graduate Program in Anesthesia Nursing at Fort Sam Houston, Texas, and a $99.9 thousand purchase order from the Department of Veterans Affairs Veterans Integrated Service Network 17 for an ultrasound simulator. The vendor also provides LearningSpace Matrix Warranty Plans to the Uniformed Services University of the Health Sciences and holds a sole-source $48 thousand annual support and maintenance contract with the Federal Emergency Management Agency for LearningSpace training systems at the Center for Domestic Preparedness.

Customer concentration is heavily skewed toward defense medical logistics. The Defense Logistics Agency Troop Support Medical accounts for 825 awards (47% of the portfolio) with $96.9 million in combined potential value, while the Department of the Army Medical Command represents 66 awards anchoring $191.6 million—the single largest dollar concentration. Together these two customers represent 62% of award volume and 64% of combined potential dollars. The Department of the Air Force, Department of the Navy Bureau of Medicine and Surgery, and the Department of the Army round out the top-five customer set. The vendor's work spans 103 distinct federal agencies, reflecting broad penetration in military healthcare facilities and VA networks.

Elevate Healthcare operates primarily through three parent contract vehicles. The Professional Services Schedule (GSA Multiple Award Schedule) carries 650 task orders worth $48.8 million combined potential value, representing the largest vehicle footprint. An indefinite delivery contract (SPE2DH19D0017) with the Defense Logistics Agency Troop Support Medical hosts 432 task orders valued at $8 million and was originally awarded in 2019 for hospital supplies and support services through September 2024. A separate DLA Medical Capital Equipment Program vehicle carries 387 task orders worth $15.2 million. The vendor's categorization spans professional and management development training (659 awards), medical, dental, and hospital equipment supplies merchant wholesaling (452 awards), and surgical and medical instrument manufacturing (450 awards) — reflecting the breadth of products delivered from training services to hard goods.

Award activity has contracted sharply in recent years. The vendor recorded 110 awards in 2022, declining to 56 in 2023, 65 in 2024, and only 3 in 2025 and 1 through May 2026. Only $186 thousand in combined potential value reaches ultimate completion in the next twenty-four months, indicating minimal near-term recompete risk on existing vehicles but also flagging weak recent pipeline momentum. Obligated dollars across the portfolio total $126.6 million (27% of combined potential value), suggesting backlog concentration in awards placed two or more years prior. The vendor does not subcontract on federal awards; its 1,758 awards are 100% prime, and no sub-award activity appears in the source. Elevate Healthcare's federal footprint is exclusively product-delivery and maintenance-support driven, with no apparent role as a sub to larger prime contractors on defense or civilian programs.